You have a chance of qualifying for this trial. We made sure your application will take less than 5 minutes.
What conditions do you have?
What conditions do you have?
The objective of this research study is to evaluate the effect of a quality improvement initiative carried out by a health system opioid stewardship task force aiming to increase clinician post-operative prescribing adherence with procedure specific guidelines that were developed using patient reported data. The feedback compares the clinician's average number of opioid pills prescribed after a given procedure to other clinicians in the health system and to the health system guideline recommended amount based on patient reported data on opioid pills taken for that procedure. The feedback also provides historical data on mean patient reported number opioid pills taken following a given procedure and on patients' ability to manage pain among those who received guideline adherent prescriptions compared with patients who received greater than the guideline recommended amount.
Primary Treatment: Opioid Prescribing Report Cards · No Placebo Group · N/A
Opioid Prescribing Report Cards
Experimental Group · 1 Intervention: Opioid Prescribing Report Cards · Intervention Types: Other
Standard FeedbackNoIntervention Group · 1 Intervention: Standard Feedback · Intervention Types:
Screening: ~3 weeks
Reporting: the duration of the study; two years
Closest Location: University of Pennsylvania · Philadelphia, PA
2011First Recorded Clinical Trial
1 TrialsResearching Opioids
1053 CompletedClinical Trials
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
1,797 Previous Clinical Trials
36,106,012 Total Patients Enrolled
1 Trials studying Opioids
108 Patients Enrolled for Opioids
Dan Lee, MDPrincipal InvestigatorUniversity of Pennsylvania
Zarina Ali, MDPrincipal InvestigatorUniversity of Pennsylvania
2 Previous Clinical Trials
857 Total Patients Enrolled
M. Kit Delgado, MD, MSPrincipal InvestigatorUniversity of Pennsylvania
3 Previous Clinical Trials
2,328 Total Patients Enrolled
Anish Agarwal, MD, MPHPrincipal InvestigatorUniversity of Pennsylvania
Age Any Age · All Participants · 3 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:
You are a surgeon or an advanced practice provider who has written at least 5 opioid prescriptions per month for patients undergoing an eligible procedure during the baseline period or an attending surgeon who performed an eligible procedure during the baseline period.
Patients will be included in the primary sample if they (1) undergo an eligible surgical procedure by an eligible attending surgeon, and (2) the proportion of guideline compliant prescriptions written during the baseline period for that procedure was less than 90%.
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
White H. A Heteroskedasticity-Consistent Covariance-Matrix Estimator and a Direct Test for Heteroskedasticity. Econometrica 1980;48:817-38.